[Clinicopathological study of pulmonary hamartoma with special reference to 6 patients who also had another tumor].

Abstract

We studied 22 patients in whom intrapulmonary hamartoma was diagnosed between 1975 and 1994. Twelve were men and 10 were women, and their ages ranged from 20 to 72 years (averaged: 52.5). The sizes of the hamartomas ranged from 5 mm to 3 cm. Five patients also had other types of cancer (ling 3, colon 1, thyroid 1) and one had a mediastinal tumor (1). In those 6 patients, the hamartomas had to be distinguished from intrapulmonary metastasis. In 2 of those 6, thoracoscopic surgery was useful for obtaining sufficient materials for diagnosis. In one patient immunohistochemical analysis with anti-PCNA (proliferative cell nuclear antigen) antibody was useful in distinguishing leiomyomatous hamartoma from benign metastatic leiomyoma.

• Authors: Y Abe, S Shioya, Y Ohshika, E Ota, M Iwasaki, H Inoue, M Nakamura, T Ogata, N Tamaoki
• Journal: Nihon Kyobu Shikkan Gakkai zasshi (Nihon Kyobu Shikkan Gakkai Zasshi) Vol. 34 Issue 12 Pg. 1354-8 (Dec 1996) ISSN: 0301-1542 [Print] Japan
• PMID: 9022319 (Publication Type: English Abstract, Journal Article)

Chemical References

• Proliferating Cell Nuclear Antigen

Topics

• Adult
• Aged
• Colonic Neoplasms (complications)
• Diagnosis, Differential
• Female
• Hamartoma (complications, pathology)
• Humans
• Immunohistochemistry
• Lung Diseases (complications, pathology)
• Lung Neoplasms (complications)
• Male
• Middle Aged
• Proliferating Cell Nuclear Antigen (analysis)
• Thyroid Neoplasms (complications)